Open AccessRadiotherapy concurrent with weekly gemcitabine after transurethral tumor resection in muscle ınvasive bladder cancer
Author(s) -
HavvaYesil Cinkir,
Umut Demırcı,
Ömer Dızdar,
MFaik Cetindag,
Serkan Altınova,
Atiye Yılmaz ÖZSAVRAN,
DidemSener Dede,
Nurgul Kızılırmak,
FAysun Eraslan,
Bülent Yalçın
Publication year - 2014
Publication title -
journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/0973-1482.147381
Subject(s) - gemcitabine , medicine , resection , bladder cancer , chemo radiotherapy , radiation therapy , urology , oncology , cancer , surgery
In this report, we determined the efficacy and the toxicity of low dose weekly gemcitabine with radiotherapy, in medically unfit or refused surgery muscle-invasive bladder cancer (BC) patients.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom